494 related articles for article (PubMed ID: 27278135)
1. Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations : A joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension.
Weber T; Lang I; Zweiker R; Horn S; Wenzel RR; Watschinger B; Slany J; Eber B; Roithinger FX; Metzler B
Wien Klin Wochenschr; 2016 Jul; 128(13-14):467-79. PubMed ID: 27278135
[TBL] [Abstract][Full Text] [Related]
2. [Blood pressure goals on the test bench].
Slany J
Wien Klin Wochenschr; 2011 Oct; 123(19-20):571-84. PubMed ID: 21935648
[TBL] [Abstract][Full Text] [Related]
3. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
[TBL] [Abstract][Full Text] [Related]
4. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension.
Chiang CE; Wang TD; Li YH; Lin TH; Chien KL; Yeh HI; Shyu KG; Tsai WC; Chao TH; Hwang JJ; Chiang FT; Chen JH;
J Formos Med Assoc; 2010 Oct; 109(10):740-73. PubMed ID: 20970072
[TBL] [Abstract][Full Text] [Related]
5. Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry.
Lang IM; Badr-Eslam R; Greenlaw N; Young R; Steg PG
Wien Klin Wochenschr; 2017 Dec; 129(23-24):879-892. PubMed ID: 28913755
[TBL] [Abstract][Full Text] [Related]
6. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
7. [Target values in hypertension treatment. Will they apply in older patients with hypertension, diabetics and in patients with IHD?].
Widimský J
Vnitr Lek; 2009 Sep; 55(9):833-40. PubMed ID: 19785385
[TBL] [Abstract][Full Text] [Related]
8. [Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016].
Schernthaner G; Drexel H; Rosenkranz A; Schernthaner GH; Watschinger B
Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S62-7. PubMed ID: 27052224
[TBL] [Abstract][Full Text] [Related]
9. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
10. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
Messerli FH; Mancia G; Conti CR; Hewkin AC; Kupfer S; Champion A; Kolloch R; Benetos A; Pepine CJ
Ann Intern Med; 2006 Jun; 144(12):884-93. PubMed ID: 16785477
[TBL] [Abstract][Full Text] [Related]
11. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?
Messerli FH; Panjrath GS
J Am Coll Cardiol; 2009 Nov; 54(20):1827-34. PubMed ID: 19892233
[TBL] [Abstract][Full Text] [Related]
12. Optimal medical treatment of hypertension in patients with coronary artery disease.
Mahtta D; Elgendy IY; Pepine CJ
Expert Rev Cardiovasc Ther; 2018 Nov; 16(11):815-823. PubMed ID: 30295548
[TBL] [Abstract][Full Text] [Related]
13. The J-curve in arterial hypertension: fact or fallacy?
Tsika EP; Poulimenos LE; Boudoulas KD; Manolis AJ
Cardiology; 2014; 129(2):126-35. PubMed ID: 25227573
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
Vidal-Petiot E; Ford I; Greenlaw N; Ferrari R; Fox KM; Tardif JC; Tendera M; Tavazzi L; Bhatt DL; Steg PG;
Lancet; 2016 Oct; 388(10056):2142-2152. PubMed ID: 27590221
[TBL] [Abstract][Full Text] [Related]
15. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
16. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
[TBL] [Abstract][Full Text] [Related]
17. The Swedish National Programme for Quality Control of Secondary Prevention of Coronary Artery Disease--results after one year.
Stagmo M; Israelsson B; Brandström H; Hedbäck B; Lingfors H; Nilsson P; Erhardt L
Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):18-24. PubMed ID: 15167202
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a lower target blood pressure for people with heart disease.
Rosendorff C; Black HR
Curr Opin Cardiol; 2009 Jul; 24(4):318-24. PubMed ID: 19395951
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
